Cerebrospinal fluid metabolites as marker for the severity of progressive post-hemorrhagic ventricular dilatation in preterm infants

Cerebrospinal fluid metabolites as marker for the severity of progressive post-hemorrhagic ventricular dilatation in preterm infants - Cerebrospinal fluid metabolites in post-hemorrhagic ventricular dilatation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30135

Enrollment

125

Registered

2006-08-24

Start date

2006-09-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hydrocephalus after cerebral bleeding

Interventions

None listed

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Preterm infants (gestational age

Exclusion criteria

Exclusion criteria: congenital cerebral malformation cerebral parenchymal hemorrhage/infarction periventricular leucomalacia PHVD already present at birth infection of the CNS metabolic disorder

Design outcomes

Primary

Measure	Time frame
The concentration of brain specific proteins and glucose in CSF, the severity of ventricular dilatation, VP drain insertion and neurodevelopmental outcome at the age of 2 year.	—

Secondary

Measure	Time frame
None.	—

Countries

Netherlands

Outcome results